The litigation that began in state court over the diabetes drug Invokana should be handled in federal court, a district judge has ruled.
U.S. District Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania ruled Wednesday in Portnoff v. Janssen Pharmaceuticals that the federal courts should keep jurisdiction over the 106 Invokana cases that were filed last year in the Philadelphia Court of Common Pleas.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
